Oliver Wyman May 12, 2022
Tobias Handschuh

KEY TAKEAWAY

Global #pharmceutical sales took a hit during #COVIDlockdowns, some dropping 10% or more. Some are rebounding. Our analysis looks at 4 areas & their projected return to normal. #OWHealth

During the height of the COVID-19 pandemic, health systems and other providers across the globe were forced to take drastic actions as utilization reached capacity. Hospitals and governments halted elective procedures. Imaging services were prioritized for the most critical patients. Staffing resources were redirected to COVID-stricken patients.

The impact of these actions rippled across the industry. In England and Wales, roughly 2.4 million operations were estimated to have been cancelled in 2021. During three-month period in 2020, US hospitals were projected to have lost $22.3 billion from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer
Pharma Pulse 4/19/24: The Health and Healthcare of Gen-Z, Long-Acting Drugs May Revolutionize HIV Prevention/Treatment & more
Recursion, Canaan, Metsera and more—Chutes & Ladders

Share This Article